ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Joint Structure"

  • Abstract Number: 2099 • ACR Convergence 2024

    A Longitudinal Study of Infrapatellar Fat Pad Morphologies as Predictive Markersin Knee Osteoarthritis

    Jean-Pierre Pelletier1, Patrice Paiement1, François Abram2, Marc Dorais3 and Johanne Martel-Pelletier1, 1Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Montreal, QC, Canada, 2Osteoarthritis Research Unit, University of Montreal Hospital Research Center (CRCHUM), Montreal, QC, Canada, 3StatSciences Inc., Notre-Dame de l'Île-Perrot, QC, Canada

    Background/Purpose: Currently, no established marker effectively stratifies knee osteoarthritis (OA) patients into subgroups. The infrapatellar fat pad (IPFP) has been proposed as a potential key…
  • Abstract Number: 1984 • ACR Convergence 2023

    Therapeutic Effects of Pentosan Polysulfate Sodium on Clinical and Disease Modifying Outcomes in Subjects with Knee Osteoarthritis

    Mukesh Ahuja1, Donna Skerrett2, Curtis Gravance3, Divya Navuru4, Ravi Krishnan5, Charles Inderjeeth6, Philip Bloom7 and Schnitzer Thomas8, 1Paradigm Biopharmaceuticals, Oak Brook, IL, 2Paradigm Biopharmaceuticals, New York, NY, 3Paradigm Biopharmaceuticals, Melba, ID, 4Paradigm Biopharmaceuticals, Melbourne, Australia, 5Paradigm Biopharmaceuticals, Adelaide, Australia, 6University of Western Australia / Linear Clinical Research, Perth, Australia, 7Sportsmed Biologic, Melbourne, Australia, 8Northwestern University Feinberg School of Medicine, Chicago, IL

    Background/Purpose: Osteoarthritis (OA) is an inflammatory joint disease, causing chronic pain, disability, and reduced quality of life. Affected joints may include the knee, hip, and…
  • Abstract Number: 2426 • ACR Convergence 2023

    The Role of β-catenin in Synovial Lining Fibroblast Differentiation

    Sonia Presti1, Gerald F.M. Watts1, Junning Case1, Zhu Zhu2, Teri Bowman1, Hung Nguyen1, Gabriel Nigrovic1, Ce Gao1, Kartik Bhamidipati1, Yuhong Li1, Suppawat Kongthong1, Fan Zhang3, Anna Helena Jonsson1, Accelerating Medicines Partnership Program (AMP RA/SLE) Network4, STARS BWH1, Michael Brenner5, Shideh Kazerounian1 and Kevin Wei5, 1Brigham and Women's Hospital, Boston, MA, 210x Genomics, St. Louis, MO, 3University of Colorado, Aurora, CO, 4National Institute of Arthritis and Musculoskeletal and Skin Diseases, Boston, MA, 5Brigham and Women's Hospital and Harvard Medical School, Boston, MA

    Background/Purpose: In healthy synovium, lining fibroblasts promote joint health by secreting proteoglycans that lubricate the joint cavity. In rheumatoid arthritis (RA), sublining fibroblasts undergo marked…
  • Abstract Number: 0750 • ACR Convergence 2023

    Multispectral Optoacoustic Tomography of the Entheses Reveals Common Metabolic and Architectural Tissue Patterns in Psoriasis and Psoriatic Arthritis Independent of Inflammation

    Filippo Fagni1, Koray Tascilar1, Rita Noversa de Sousa2, Sara Bayat1, Lukas Sollfrank3, Arnd Kleyer4, Michael Sticherling5, Adrian Regensburger6, Ferdinand Knieling6, Georg Schett7, Maximilian Waldner8 and David Simon1, 1Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg & Universitätsklinikum Erlangen, Department of Internal Medicine 3 - Rheumatology and Immunology / Deutsches Zentrum Immuntherapie, Erlangen, Germany, 2Department of Internal Medicine 3, Friedrich-Alexander University (FAU) Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany, 3Department Dermatology, Friedrich-Alexander University (FAU) Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany, 4University Hospital Erlangen, Erlangen, Germany, 5Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg & Universitätsklinikum Erlangen, Department of Dermatology, Erlangen, Germany, 6Department of Pediatrics and Adolescent Medicine, Friedrich-Alexander University (FAU) Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany, 7Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany, 8Department of Internal Medicine 1, Friedrich-Alexander University (FAU) Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany

    Background/Purpose: Multispectral optoacoustic tomography (MSOT) is a novel imaging platform that combines ultrasound (US) with optoacoustic imaging to allow non-invasive in vivo quantification of key…
  • Abstract Number: 1309 • ACR Convergence 2023

    Refractory RA Patients for Targeted Therapies in Real Life

    Elena Grau Garcia1, Laura Mas Sanchez2, Pablo Francisco Muñoz Martínez3, Carmen Riesco Barcena1, Alba Maria Torrat Noves1, Daniel Ramos Castro1, Anderson Victor Huaylla Quispe1, Iago Alcantara Alvarez1, Belen Villanueva Mañez1, Ernesto Tovar Sugrañes1, Elvira Vicens Bernabeu1, Hikmat Charia1, Marta De la Rubia Navarro2, Luis Gonzalez Puig1, Jose Ivorra Cortes1, Samuel Leal Rodriguez1, Isabel Martinez Cordellat1, Rosa Negueroles Albuixech1, Jose Eloy Oller Rodriguez1, Ines Canovas Olmos1, Carmen Najera Herranz1 and Jose Andres Roman Ivorra4, 1Rheumatology Department. HUP La Fe, Valencia, Spain, 2Rheumatology Department. HUP La Fe, Valéncia, Spain, 3Rheumatology Department. HUP La Fe, Sagunto, Spain, 4Hospital Universitari i Politècnic la Fe, Valencia, Spain

    Background/Purpose: Despite the increasing number of available targeted therapies (TT) in rheumatoid arthritis (RA), a proportion of RA patients fail to respond to their first…
  • Abstract Number: 1732 • ACR Convergence 2023

    Immunopathogenesis and Preclinical Trials in a Humanized Mouse Model of Rheumatoid Arthritis(RA)

    Huiyi Wang1, Kangkang Luo1, Shuxin Xu1, Jiayin Zhou1, Santi Chen2, Jun wang2, Wenzhao Li2, Jing Zhao1 and Cunxiang Ju1, 1GemPharmatech CO., Ltd., Nanjing, China, 2GemPharmatech LLC, La Jolla, CA

    Background/Purpose: The differences between human and mouse immune systems make it challenging to accurately reflect the immunopathogenesis of autoimmune diseases in patients. Therefore, translational research…
  • Abstract Number: 1865 • ACR Convergence 2023

    Is Flexion Contracture in Knee Osteoarthritis Associated with MRI Pathologies over Time? Data from the Osteoarthritis Initiative

    Daniel Chan Chun Kong1, Philip Conaghan2 and Mark Campbell3, 1University of Ottawa, Ottawa, ON, Canada, 2University of Leeds, Leeds, United Kingdom, 3Elisabeth Bruyere Hospital, Ottawa, ON, Canada

    Background/Purpose: Knee flexion contracture (FC) is associated with worse clinical outcomes in those with knee OA. Cross sectional data demonstrated that knee FC was associated…
  • Abstract Number: 1886 • ACR Convergence 2023

    Costotransverse Joint Ankylosis and Association with Syndesmophyte Progression in Patients with Radiographic Axial Spondyloarthritis

    Hong Ki Min1, Se Hee Kim2, Hae-Rim Kim3, Sang-Heon Lee1 and Sang-Hoon Lee2, 1Konkuk University School of Medicine, Seoul, South Korea, 2Kyung Hee University Hospital at Gangdong, Seoul, South Korea, 3Rheumatology, Konkuk University Medical Center, Seoul, South Korea

    Background/Purpose: Costotransverse joint ankylosis in radiographic axial spondyloarthritis (r-axSpA) patients was measured. Furthermore, the association between syndesmophyte progression assessed by CT syndesmophyte score (CTSS) and…
  • Abstract Number: 1982 • ACR Convergence 2023

    Effect of Denosumab on Knee Pain and Bone Marrow Lesions in Symptomatic Knee Osteoarthritis

    Terence O'Neill1, Matthew Parkes1, Michael Bowes2, Richard Hodgson1 and David Felson3, 1University of Manchester, Manchester, United Kingdom, 2Imorphics, Manchester, United Kingdom, 3Boston University, Boston, MA

    Background/Purpose: There are currently no licensed therapies which reduce progression of knee OA. Current therapies focus on reducing pain, have limited effect, and some have…
  • Abstract Number: 0267 • ACR Convergence 2022

    Cancer Risk with Biologic and Targeted Synthetic DMARDs in Patients with Rheumatic Diseases and Previous Malignancy: Results from the BIOBADASER Register

    Juan Molina1, Fernando Sanchez-Alonso2, Cristina Bohorquez3, Cesar Diaz-Torne4, Carolina Perez-Garcia5, Juan Maria Blanco-Madrigal6, Paloma Vela-Casampere7, José María Älvaro-Gracia1 and Isabel Castrejon8, 1Hospital General Universitario Gregorio Marañón, Madrid, Spain, 2Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain, 3University Hospital Príncipe de Asturias, Immune System Diseases-Rheumatology Service, Alcalá de Henares, Madrid, Spain, 4Department of Rheumatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, 5Department of Rheumatology, Hospital del Mar, Barcelona, Spain, 6Department of Rheumatology, Hospital de Basurto, Bilbao, Spain, 7Hospital General Universitario Alicante, Alicante, Spain, 8Hospital Universitario Gregorio Marañón, Madrid, Spain

    Background/Purpose: To investigate the occurrence and relative risk of incident malignancy in patients with rheumatic diseases and previous malignancy treated with biologic and targeted synthetic…
  • Abstract Number: 0404 • ACR Convergence 2022

    Site-Specific Responses of Joint and Entheses to Tofacitinib in Patients with Ankylosing Spondylitis: A Post Hoc Analysis of a Phase 3 Trial

    Raphael Micheroli1, Tim Killeen2, Hyejin Jo3, Kenneth Kwok3, Bassel Elzorkany4, Caroline Ospelt5, Adrian Ciurea6 and Michael Nissen7, 1University Hospital Zurich, Department of Rheumatology, Zürich, Switzerland, 2Pfizer Ltd, Tadworth, Switzerland, 3Pfizer Inc, New York, NY, 4Department of Rheumatology, Cairo University, Cairo, Egypt, 5Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich, Zürich, Switzerland, 6University Hospital Zurich, Zürich, Switzerland, 7Hopitaux Universitaires de Genève, Geneva, Switzerland

    Background/Purpose: Sites of peripheral joint and enthesitis involvement in AS vary. Tofacitinib is an oral Janus kinase inhibitor for the treatment of AS. Differential site-specific…
  • Abstract Number: 0504 • ACR Convergence 2022

    Three-dimensional Ground Reaction Force Symmetry Metrics Largely Fail to Explain Cartilage Worsening in the Contralateral Knee in Persons with Unilateral Knee Osteoarthritis: The Multicenter Osteoarthritis Study

    Patrick Corrigan1, Cara Lewis2, Kerry Costello2, Ali Guermazi2, Frank Roemer3, Deepak Kumar2, David Felson2, Kathryn Bacon2, Tuhina Neogi4, Michael LaValley5, Michael Nevitt6, Cora E. Lewis7, James Torner8 and Joshua Stefanik9, 1Saint Louis University, St. Louis, MO, 2Boston University, Boston, MA, 3Friedrich-Alexander University Erlangen Nürnberg, Erlangen, Germany, 4Boston University School of Medicine, Boston, MA, 5Boston University School of Public Health, Arlington, MA, 6University of California San Francisco, Orinda, CA, 7University of Alabama at Birmingham, Birmingham, AL, 8University of Iowa, Iowa City, IA, 9Northeastern University, Boston, MA

    Background/Purpose: Knee osteoarthritis (KOA) often starts as a unilateral disease and commonly progresses to bilateral KOA. There is a need to identify mechanisms that explain…
  • Abstract Number: 0610 • ACR Convergence 2022

    Patient-derived Organoids Reveal Transcriptional Regulation of Synovial Lining Fibroblast Differentiation

    Sonia Presti1, Gerald FM Watts1, Zhu Zhu1, Kartik Bhamidipati1, Junning Case1, Yuhong Li1, Teri Bowman1, Suppawat Kongthong1, ilya Korsunsky1, Michael Brenner2 and Kevin Wei3, 1Brigham and Women's Hospital, Boston, MA, 2Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 3Brigham and Women's Hospital and Harvard Medical School, Boston, MA

    Background/Purpose: Synovial lining fibroblasts secrete factors into the joint cavity that promote joint lubrication1. In inflammatory arthritis, sublining fibroblasts undergo marked expansion while lining fibroblasts…
  • Abstract Number: 0803 • ACR Convergence 2022

    Performance of Adenosine Deaminase Activity in Sinovial Fluid for the Early Diagnosis of Tuberculous Arthritis: A Meta Analysis

    Juan Carlos Cortés-Quiroz1, Javier Ena2, José Antonio Bernal3 and José Rosas4, 1Marina Baixa Hospital, Mutxamel, Spain, 2Department of Internal Medicine. Marina Baixa Hospital, Villajoyosa, Spain, 3Rheumatology Department. Marina Baixa Hospital, Alicante, Spain, 4Rheumatology Department, Hospital Marina Baixa, Villajoyosa, Spain

    Background/Purpose: Adenosine deaminase (ADA) activity has shown good performance in diagnosing pleural, peritoneal, and meningeal tuberculosis. This study aimed to evaluate the performance of measuring…
  • Abstract Number: 0972 • ACR Convergence 2022

    Automated Joint Space Width Measurement for Hand Osteoarthritis: A Deep Learning Approach

    Zhiheng Chang1, Juan Shan2, Yue Wang2, Xinyue Sun3, Jeffrey Driban4, Timothy McAlindon5, Jeffrey Duryea6, Lena Schaefer6, Charles Eaton7 and Ming Zhang8, 1Wentworth Institute of Technol, Boston, MA, 2Pace University, New York, NY, 3Shandong University, Qing Dao, Shandong, China, 4Tufts Medical Center, Westborough, MA, 5Tufts Medical Center, Arlington, MA, 6Brigham and Women's Hospital, Boston, MA, 7Brown University, Pawtucket, RI, 8Boston University, Westford, MA

    Background/Purpose: Hand osteoarthritis (OA) can be assessed visually through radiographs using Kellgren and Lawrence (KL) system. However, the KL grading system is not fully objective…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology